Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Evaluation of the interactions between Human Serum Albumin (HSA) and Non‐Steroidal Anti‐Inflammatory (NSAIDs) drugs by multiwavelength molecular fluorescence, structural and computational analysis

dc.contributor.authorAmézqueta, Susana
dc.contributor.authorBeltrán Abadia, José Luis
dc.contributor.authorBolioli, Anna Maria
dc.contributor.authorCampos Vicens, Lluís
dc.contributor.authorLuque Garriga, F. Xavier
dc.contributor.authorRàfols Llach, Clara
dc.date.accessioned2021-03-10T09:43:02Z
dc.date.available2021-03-10T09:43:02Z
dc.date.issued2021-03-04
dc.date.updated2021-03-10T09:43:02Z
dc.description.abstractThe interaction between drugs and transport proteins, such as albumins, is a key factor in drug bioavailability. One of the techniques commonly used for the evaluation of the drug‐protein complex formation is fluorescence. This work studies the interaction of human serum albumin (HSA) with four non‐steroidal anti‐inflammatory drugs (NSAIDs) (ibuprofen, flurbiprofen, naproxen, and diflunisal) by monitoring the fluorescence quenching when the drug‐albumin complex is formed. Two approaches - the double logarithm Stern‐Volmer equation and the STAR program - are used to evaluate the binding parameters. The results are analyzed considering the bind‐ ing properties, determined by using other complementary techniques and the available structural information of albumin complexes with NSAID‐related compounds. Finally, this combined analysis has been synergistically used to interpret the binding of flurbiprofen to HSA.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec707665
dc.identifier.issn1424-8247
dc.identifier.pmid33806467
dc.identifier.urihttps://hdl.handle.net/2445/174869
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ph14030214
dc.relation.ispartofPharmaceuticals, 2021, vol. 14, num. 3, p. 214
dc.relation.urihttps://doi.org/10.3390/ph14030214
dc.rightscc-by (c) Amézqueta, Susana et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Enginyeria Química i Química Analítica)
dc.subject.classificationAntiinflamatoris no esteroïdals
dc.subject.classificationInteraccions medicament-nutrient
dc.subject.otherNonsteroidal anti-inflammatory agents
dc.subject.otherDrug-nutrient interactions
dc.titleEvaluation of the interactions between Human Serum Albumin (HSA) and Non‐Steroidal Anti‐Inflammatory (NSAIDs) drugs by multiwavelength molecular fluorescence, structural and computational analysis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
707665.pdf
Mida:
1.41 MB
Format:
Adobe Portable Document Format